4//SEC Filing
Ruegsegger Frederick J 4
Accession 0001181431-12-003821
CIK 0001178711other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:08 PM ET
Size
5.2 KB
Accession
0001181431-12-003821
Insider Transaction Report
Form 4
Ruegsegger Frederick J
Director
Transactions
- Award
Common Stock (right to buy)
2012-01-24+7,000→ 7,000 totalExercise: $8.18Exp: 2022-01-24→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]The option vests in twelve equal monthly installments beginning on February 24, 2012.
Documents
Issuer
Transcept Pharmaceuticals Inc
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001428158
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 4:08 PM ET
- Size
- 5.2 KB